Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder
Clinical trial NCT06605599 · COMPLETED
Trial details
- NCT number
- NCT06605599
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2025-11-12
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.